Enliven Therapeutics, Inc.

NASDAQ:ELVN

20.06 (USD) • At close June 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20242023202220212020201920182017
Operating Activities:
Net Income -89.024-71.584-37.662-24.74-18.966-23.463-11.3370
Depreciation & Amortization 0.3170.2970.2150.1150.0450.03300
Deferred Income Tax 000-3.8090-0.21500
Stock Based Compensation 20.17412.9143.1911.9240.130.8990.5550
Change In Working Capital -4.5411.4010.4383.5670.5830.6731.235-0.188
Accounts Receivables 00000000
Inventory 00000000
Accounts Payables 0.81-2.250.4111.7340.2910.750.477-0.666
Other Working Capital -5.3513.6510.0271.8330.292-0.0770.7580.478
Other Non Cash Items -0.118-4.2971.7413.8099.6790.1960.848-7.931
Operating Cash Flow -73.192-61.269-32.077-19.134-8.529-21.877-8.777-8.785
Investing Activities:
Investments In Property Plant And Equipment -0.044-0.149-0.612-0.191-0.461-0.1400
Acquisitions Net 003500000
Purchases Of Investments -350.74-268.263-35-47.557-64.203-23.9200
Sales Maturities Of Investments 313.91412041.87845.93747.5000
Other Investing Activites 0.8730-41.8781.6216.703000
Investing Cash Flow -35.997-148.412-0.612-0.191-0.461-24.0600
Financing Activities:
Debt Repayment 00000-1.99600
Common Stock Issued 39.188161.2010.5910.690.1445.5756.48811
Common Stock Repurchased 00000000
Dividends Paid 00000000
Other Financing Activities 93.977234.286-1.799-1.242260.88606.48811
Financing Cash Flow 133.165234.286-1.799-1.016130.51343.5796.48811
Other Information:
Effect Of Forex Changes On Cash 0074.20200-0.08800
Net Change In Cash 23.97624.605-34.488-20.341121.523-2.446-2.2892.215
Cash At End Of Period 124.171100.19575.59110.078130.4194.9367.3829.671